Sangamo Therapeutics, Inc. (SGMOQ) News
Follow Sangamo Therapeutics, Inc. (SGMOQ) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Sangamo Therapeutics Secures Replacement Financing in Chapter 11
Sangamo Therapeutics secured replacement financing while in Chapter 11 proceedings.
EQUITY | Oct 27, 2026, 08:06 PM UTC
M
Sangamo to sell ST-920 Fabry assets to PTC for $111 million
Sangamo Therapeutics plans to sell its ST-920 Fabry assets to PTC for $111 million, plus milestones.
EQUITY | Aug 28, 2026, 08:15 PM UTC